Prof. Dr. DIETER STEINHILBER

CEO / CFO

  • Expert in pharmacology                                          
  • Founding of a start-up and successfull exit

 

 

 

 

Dr. Meike Saul

CSO

  • Discovered miR-574-5p as therapeutic target
  • Conceived the process of its development

 

 

 

 

Prof. Dr. AIMO KANNT

Scientific Advisor

  • Expert in drug research and development
  • Expert in pharma project management